Association of sets of alleles of genes encoding β3-adrenoreceptor, uncoupling protein 1 and lipoprotein lipase with increased risk of metabolic complications in obesity

International Journal of Obesity

Volumn 24, Issue 1, 2000, Pages 93-100

  Proenza, A M ^a,b   Poissonnet, C M ^a   Ozata, M ^c   Ozen, S ^c   Guran, S ^c   Palou, A ^b   Strosberg, Ad ^a  

^a CNRS   (France)

^b UNIVERSITAT DE LES ILLES BALEARS   (Spain)

^c GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

DNA polymorphisms; Lipoprotein lipase; Metabolic disorders of obesity; Uncoupling protein; 3 adrenoreceptor

Indexed keywords

BETA 3 ADRENERGIC RECEPTOR; CHOLESTEROL; GLUCOSE; LIPOPROTEIN LIPASE; TRIACYLGLYCEROL; UNCOUPLING PROTEIN 1;

ADULT; ANTHROPOMETRY; ARTICLE; BLOOD PRESSURE; BODY HEIGHT; BODY MASS; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL; TURKEY (REPUBLIC);

EID: 0033982184     PISSN: 03070565     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijo.0801091     Document Type: Article

References (34)

1. 1 Vohl MC, Lamarche B, Moorjani S, Prud'homme D, Nadeau A, Bouchard C Lupien PJ, Despré JP. The lipoprotein lipase HindIII polymorphism modulates plasma triglyceride levels in visceral obesity. Arterioscler Thromb Vasc Biol 1995; 15: 714-720.
2. 2 Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994; 372: 425-432.
3. 3-adrenergic-receptor gene. New Engl J Med 1995; 333: 343-347.
4. 3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity. New Engl J Med 1995; 333: 352-354.
5. 3-adrenergic receptor gene is associated with obesity and hyperinsulinemia in Japanese subjects. Biochem Biophys Res Commun 1995; 215: 555-560.
6. 6 Widén E, Lehto M, Kanninen T, Walston J, Shuldiner AR, Groop LC. Association of a polymorphism in the β3-adrenergic-receptor gene with features of the insulin resistance syndrome in Finns. New Engl J Med 1995; 333: 348-351.
7. 3-adrenoreceptor polymorphism with obesity and diabetes: Current status. Trends Pharmac Sci 1997; 18: 449-454.
8. 3-adrenergic receptor gene on weight gain in morbid obesity, Int J Obes 1996; 20: 1062-1066.
9. 9 Chamberlain JC, Thorn JA, Oka K, Galton DJ, Stocks J. DNA polymorphisms at the lipoprotein lipase gene: Associations in normal and hypertriglyceridaemic subjects. Atherosclerosis 1989; 79: 85-91.
10. 10 Wang XL, McCredie RM, Wilcken DEL. Common DNA polymorphism at the lipoprotein lipase gene. Association with severity of coronary artery disease and diabetes. Circulation 1996; 93: 1339-1345.
11. 11 Palou A, Pico C, Bonet ML, Oliver P. Molecules in focus: Uncoupling protein. Int J Biochem Cell Biol 1998; 30: 7-11.
12. 12 Anderson KM, Kannel WB. Obesity and disease. In Björntorp P, Brodoff BN (eds). Obesity. Lippincott: Philadelphia, PA, 1992, pp 465-473.
13. 13 Mahley RW, Palaoglu KE, Atak Z, Dawson-Pepin J, Langlois AM, Cheung V, Onat H, Fulks P, Mahley LL, Vakar F, Ozbayrakçl S, Gökdemir O, Winkler W. Turkish heart study: Lipids, lipoproteins, and apolipoproteins. J Lipid Res 1995; 36: 839-859.
14. 14 National Diabetes Data group. Classification of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979; 28: 1039-1057.
15. 15 Trinder P. Determination of glucose in blood using glucose oxidase with an alternative oxygen acceptor. Ann Clin Biochem 1969; 69: 24-27.
16. 16 Barham D, Trinder P. An improved colour reagent for the determination of blood glucose by the oxidase system. Analyst 1972; 97: 142-145.
17. 17 Allain CC, Poon LS, Chan CS, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem 1974; 20: 470-475.
18. 18 Bucolo G, David H. Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem 1973; 19: 476-482.
19. 19 Megraw RE, Dunn DE, Biggs HG. Manual and continuousflow colorimetry of triacylglycerols by a fully enzymic method. Clin Chem 1979; 25: 273-278.
20. 20 Sambrook J, Fritsch EF, Maniatis T. In Molecular cloning, 2nd ed. Cold Spring Harbor Laboratory Press: Cold Spring Harbor, 1989, pp 9.14-9.23.
21. 21 Cassard-doulcier AM, Bouillaud F, Chagnon M, Gelly C, Dionne FT, Oppert JM, Bouchard C, Chagnon Y, Ricquier D. The BclI polymorphism of the human uncoupling protein (UCP) gene is due to a point mutation in the 5′ - flanking region. Int J Obes 1996; 20: 278-279.
22. 22 Ahn YI, Kamboh MI, Hamman RF, Cole SA, Ferrell RE. Two DNA polymorphisms in the lipoprotein lipase gene and their associations with factors related to cardiovascular disease. J Lipid Res 1993; 34: 421-428.
23. 23 Togan I, Ergüven A. Red cell enzyme and blood group polymorphisms in Turkey. Gene Geog 1994; 8: 75-80.
24. 24 Gerdes C, Gerdes LU, Hansen PS, Faergeman O. Polymorphisms in the lipoprotein lipase gene and their associations with plasma lipid concentrations in 40-year-old Danish men. Circulation 1995; 92: 1765-1769.
25. 25 Jemaa R, Tuzet S, Portos C, Betoulle D, Apfelbaum M, Fumeron F. Lipoprotein lipase gene polymorphisms: associations with hypertriglyceridemia and body mass index in obese people. Int J Obes 1995; 19: 270-274.
26. 26 Lonnqvist F, Thorne A, Nilsell K, Hoffstedt J, Arner P. A pathogenic role of visceral fat β3-adrenoceptors in obesity. J Clin Invest 1995; 95: 1109-1116.
27. 27 Lonnqvist F, Thorne A, Large V, Arner P. Sex differences in visceral fat lipolysis and metabolic complications of obesity. Arteriorscler. Thromb. Vasc. Biol. 1997; 17(7): 1472 1480.
28. 28 Willett WC, Manson JE, Stampfer MJ, Colditz GA, Rosner B, Speizer FE, Hennekens CH. Weight, weight change and coronary heart disease in women: Risk within the normal weight range. JAMA 1995; 273(6): 461-465.
29. 29 Borkan GA, Sparrow D, Wisniewski C, Vokonas PS. Body weight and coronary disease risk: Patterns of risk factor change associated with long-term weight change. The Normative Ageing Study. Am J Epidemiol 1986; 124: 410-419.
30. 30 Anderson KM, Wilson PW, Garrison RJ, Castelli WP. Longitudinal and secular trends in lipoprotein cholesterol measurements in a general population sample. Atherosclerosis 1987; 68: 59-66.
31. 31 Lapidus L, Bengtsson C, Larsson B, Pennert K, Rybo E, Sjostrom L. Distribution of adipose tissue and risk of cardiovascular disease and death: a 12-year follow-up of participants in the population study of women in Gothenburg, Sweden. Br Med J 1984; 289: 1257-1261.
32. 32 Caro J. Insulin resistance in obese and non obese man. J Clin Endocrinol Metab 1990; 73: 691-695.
33. 33 Mitchell RJ, Earl L, Bray P, Fripp YJ, Williams J. DNA polymorphisms at the lipoprotein lipase gene and their association with quantitative variation in plasma high-density lipoproteins and triacylglycerides. Human Biol 1994; 66: 383-397.
34. 34 Despres JP, Moorjani S, Lupien P-J, Tremblay A, Nadeau A, Bouchard C. Genetic aspects of susceptibility to obesity and related dyslipidemias. Mol Cell Biochem 1992; 113: 151-169.